News - Generics

Filter

Current filters:

Generics

Popular Filters

1226 to 1238 of 1238 results

US FTC finds 60% rise in pharma pay-for-delay deals; flawed understanding says GPhA

05-05-2011

Pharmaceutical companies in the USA struck an unprecedented number of deals in fiscal year 2010 in which…

GenericsLicensingNorth AmericaPharmaceutical

Teva to buy Japanese generic drugmaker Taiyo?

04-05-2011

According to Japan’s leading financial newspaper, The Nikkei, Israeli generics drug giant Teva Pharmaceutical…

Asia-PacificGenericsMergers & AcquisitionsTaiyo PharmaTeva Pharmaceutical Industries

Mylan's 1st-qtr 2011 adjusted diluted EPS up 22%, in line with forecasts

04-05-2011

US generics group Mylan (Nasdaq: MYL) reported that total revenues for the quarter ended March 31, 2011…

FinancialGenericsMylan Laboratories

European Commission opens investigation against Cephalon and Teva

03-05-2011

The European Commission has opened a formal antitrust investigation to assess whether an agreement between…

CephalonEuropeGenericsLegalTeva Pharmaceutical Industries

Hikma must sell two drugs as condition of Baxter Healthcare acquisition, says US antitrust body

29-04-2011

The USA’s Federal Trade Commission will require Jordan-based drugmaker Hikma Pharmaceuticals (LSE:…

Baxter HealthcareGenericsHikma PharmaceuticalsLegalMergers & Acquisitions

Generic drug sales in Brazil leapt 53% in 2010; double-digit growth forecast the next two years

28-04-2011

In Brazil, sales last year of generic drugs - which are nearly identical reproductions of off-patent…

GenericsMarkets & MarketingPatentsSouth America

Watson 1st-qtr 2011 net revenue Increases 2.3% to $877 million

28-04-2011

USA-based generics and specialty drugmaker Watson Pharmaceuticals (NYSE: WPI) reported net revenue of…

FinancialGenericsPharmaceuticalWatson Pharmaceuticals

AstraZeneca and Pozen sue Dr Reddy’s over Vimovo patent

27-04-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN and USA-based Pozen (Nasdaq; POZN) have filed a law suit…

Anti-Arthritics/RheumaticsAstraZenecaDr Reddy's LaboratoriesGenericsLegalNorth AmericaPatentsPharmaceuticalPozenVimovo

Hospira’s first-quarter 2011 results beat forecasts, helped by generic Taxotere

27-04-2011

Specialty drugmaker Hospira (NYSE: HSP) yesterday reported results for the first quarter ended March…

FinancialGenericsHospiraTaxotere

Alapis enters MoU with China's CSPC Pharma on areas of collaboration

18-04-2011

Greek drugmaker Alapis SA (APSHF: PK) has signed a memorandum of understanding (MoU) with one of China's…

AlapisCSPC PharmaceuticalGenericsLicensing

1226 to 1238 of 1238 results

Back to top